​
​

eFFECTOR Therapeutics Ownership | Who Owns eFFECTOR Therapeutics?

OverviewForecastRevenueFinancialsChart

eFFECTOR Therapeutics Ownership Summary

eFFECTOR Therapeutics is owned by 2.94% institutional investors, 2.91% insiders, and 94.15% retail investors. Blackstone is the largest institutional shareholder, holding 1.28% of EFTR shares. NT Ext Equity Mkt Idx Fd - NL is the top mutual fund, with 0.03% of its assets in eFFECTOR Therapeutics shares.

EFTR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockeFFECTOR Therapeutics2.94%2.91%94.15%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackstone52.34K1.28%$15.19K
Parallel advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blackstone52.34K0.00%$15.19K
Parallel advisors---

Top Buyers

HolderShares% AssetsChange
Blackstone52.34K0.00%-
Parallel advisors---67.74K

Top Sellers

HolderShares% AssetsChange
Parallel advisors---67.74K
Blackstone52.34K0.00%-

Sold Out

HolderChange
Parallel advisors-67.74K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20242-120,081-29.76%----100.00%
Mar 31, 20242-92.00%120,081-98.97%5958.91%--100.00%2-50.00%
Dec 31, 202325-13.79%11,685,202-50.21%-0.03%10-16.67%433.33%
Sep 30, 202329-17.14%23,468,478-3.95%491.45%12-14.29%3-
Jun 30, 20233529.63%24,433,6893.52%581.84%1455.56%3-50.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
NT Ext Equity Mkt Idx Fd - NL1.48K0.03%-
NT Ext Equity Mkt Idx Fd - L1.43K0.03%-
Northern Trust Extended Eq Market Idx1.43K0.03%-
NT Ext Equity Mkt Idx Fd - DC - NL - T21.19K0.03%-1.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5221.000.00%163.00
SSgA U.S. Extended Market Index Class I4.20K0.00%-
Northern Trust Wilshire 5000142.000.00%-
SSgA U.S. Total Market Index Strategy69.000.00%20.00
JHVIT Total Stock Market Index I48.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 27, 2023SR ONE CAPITAL MANAGEMENT, LLC-Sell$108.31K
Nov 27, 2023SR ONE CAPITAL MANAGEMENT, LLC-Sell$261.15K
Oct 04, 2022Ehrlich Christopher B-Buy$197.22
Sep 26, 2022Ehrlich Christopher B-Buy$10.38K
Aug 01, 2022Presidio Management Group X LLC-Sell$20.35K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q4-2
2023 Q3--
2023 Q2--

EFTR Ownership FAQ

Who Owns eFFECTOR Therapeutics?

eFFECTOR Therapeutics shareholders are primarily institutional investors at 2.94%, followed by 2.91% insiders and 94.15% retail investors. The average institutional ownership in eFFECTOR Therapeutics's industry, Biotech Stocks , is 44.97%, which eFFECTOR Therapeutics falls below.

Does Blackrock own eFFECTOR Therapeutics?

BlackRock is not among the top 10 institutional shareholders of eFFECTOR Therapeutics.

Who is eFFECTOR Therapeutics’s biggest shareholder by percentage of total assets invested?

Blackstone is eFFECTOR Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 52.34K eFFECTOR Therapeutics shares, valued at 15.18K$.

Who is the top mutual fund holder of eFFECTOR Therapeutics shares?

NT Ext Equity Mkt Idx Fd - NL is the top mutual fund holder of eFFECTOR Therapeutics shares, with 0.03% of its total shares outstanding invested in 1.48K eFFECTOR Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools